Does combining adalimumab with methotrexate improve outcomes in psoriasis? Results from 3-year follow-up data
| Errataetall: |
CommentOn: J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1815-1824. - PMID 37014287 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Journal of the European Academy of Dermatology and Venereology : JEADV - 37(2023), 9 vom: 19. Sept., Seite 1685-1686 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Smith, C R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adalimumab |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 18.09.2023 published: Print CommentOn: J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1815-1824. - PMID 37014287 Citation Status MEDLINE |
|---|
| doi: |
10.1111/jdv.19282 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361204760 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361204760 | ||
| 003 | DE-627 | ||
| 005 | 20231226084634.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jdv.19282 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361204760 | ||
| 035 | |a (NLM)37622224 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Smith, C R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Does combining adalimumab with methotrexate improve outcomes in psoriasis? Results from 3-year follow-up data |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 18.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1815-1824. - PMID 37014287 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Methotrexate |2 NLM | |
| 650 | 7 | |a YL5FZ2Y5U1 |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the European Academy of Dermatology and Venereology : JEADV |d 1997 |g 37(2023), 9 vom: 19. Sept., Seite 1685-1686 |w (DE-627)NLM091705932 |x 1468-3083 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:9 |g day:19 |g month:09 |g pages:1685-1686 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jdv.19282 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2023 |e 9 |b 19 |c 09 |h 1685-1686 | ||